Leadership Overview
Worldwide Clinical Trials has 4 executives leading key functions including strategy, operational coordination, human capital management, and oncology research.
Focused on advancing medical breakthroughs, Worldwide Clinical Trials delivers comprehensive clinical development services to biotechnology and pharmaceutical partners. This organization prioritizes scientific excellence and patient-centric research to accelerate global therapeutic innovation.
Focused on advancing medical breakthroughs, Worldwide Clinical Trials delivers comprehensive clinical development services to biotechnology and pharmaceutical partners. This organization prioritizes scientific excellence and patient-centric research to accelerate global therapeutic innovation.
Leadership Roles at Worldwide Clinical Trials
Daniel Gizachew - Chief Executive Officer
Daniel Gizachew, the Chief Executive Officer at Worldwide Clinical Trials, directs the overarching strategic vision for the global contract research organization. By overseeing the integration of preclinical and Phase I-IV clinical development services, the Chief Executive Officer ensures alignment across all therapeutic areas including Cardiovascular, Metabolic, and Neuroscience. Daniel Gizachew drives the expansion of bioanalytical sciences to support complex biotechnology and pharmaceutical programs. This leadership role involves managing high-level partnerships and maintaining the competitive market position of the firm within the international research landscape. Through the optimization of late-phase studies and real-world evidence initiatives, the Chief Executive Officer secures long-term growth and operational efficiency. By fostering a culture of scientific rigor, the Chief Executive Officer guides the company toward achieving critical milestones in drug development. Ultimately, the Chief Executive Officer maintains the reputation of the firm as a premier partner for global clinical research.
Keya Watkins - President, Oncology
Keya Watkins, the President, Oncology at Worldwide Clinical Trials, directs the specialized research strategy for the oncology therapeutic division. By overseeing the design and execution of complex oncology clinical trials, the President, Oncology ensures that biotechnology and pharmaceutical clients receive high-performing development services. Keya Watkins drives the expansion of the oncology portfolio by leveraging advanced clinical methodologies and real-world evidence. This leadership role involves collaborating with global medical teams to address the unique challenges of cancer research and patient recruitment. By optimizing the clinical trial lifecycle, the President, Oncology accelerates the path to market for innovative oncology therapies. The President, Oncology also manages the strategic relationships with key stakeholders to maintain the leadership position of the firm in the oncology sector. Through the application of deep therapeutic expertise, the President, Oncology ensures that every study meets the highest standards of scientific integrity and regulatory success.
Lisa Skorets - Chief of Staff, Gcd
Lisa Skorets, the Chief of Staff, Gcd at Worldwide Clinical Trials, coordinates cross-functional operations to streamline clinical development workflows. By managing internal communications and executive priorities, the Chief of Staff, Gcd ensures that the organization executes complex Phase I-IV projects with precision. Lisa Skorets facilitates collaboration between departments to support the delivery of high-quality bioanalytical and clinical services. This role involves monitoring operational performance metrics to drive efficiency across the global footprint of the firm. By aligning departmental goals with the broader mission of the company, the Chief of Staff, Gcd optimizes resource allocation for diverse therapeutic programs. The Chief of Staff, Gcd also manages the implementation of strategic initiatives that enhance the service delivery model for pharmaceutical clients. Through meticulous oversight of internal processes, the Chief of Staff, Gcd supports the seamless execution of clinical trials from early-phase research through post-approval studies.
Joy Clark - Chief People Officer
Joy Clark, the Chief People Officer at Worldwide Clinical Trials, architects the human capital strategy to attract and retain top-tier scientific talent. By overseeing global recruitment, professional development, and organizational culture, the Chief People Officer ensures the workforce possesses the expertise required for complex clinical development services. Joy Clark drives initiatives that promote employee engagement and operational excellence across the international offices of the firm. This leadership role involves designing compensation structures and performance management systems that align with the growth objectives of the company. By fostering an inclusive environment, the Chief People Officer supports the diverse teams working on Cardiovascular, Metabolic, and Rare Disease research. Joy Clark also manages the integration of talent during organizational scaling to maintain high standards of service delivery. Through the implementation of robust training programs, the Chief People Officer ensures the staff remains at the forefront of clinical research methodologies and regulatory compliance.
Explore Leadership Teams in Business Services
Brookings Institution operates as a nonprofit public policy research organization dedicated to generating actionable insights that address complex societal challenges. The organization conducts rigorous, in-depth research across multiple domains, translating academic inquiry into practical solutions for policymakers, business leaders, and civic stakeholders. Through its multidisciplinary approach, Brookings examines pressing issues spanning economics, governance, international affairs, and social policy, producing analysis that informs decision-making at local, national, and global scales. The institution's research methodology combines empirical investigation with expert analysis, drawing on scholars and practitioners who bring deep subject matter expertise to their work. Brookings produces comprehensive reports, policy briefs, and thought leadership that synthesize complex data into accessible recommendations. The organization's work spans both domestic policy challenges and international relations, reflecting the interconnected nature of modern governance and economic systems. Brookings maintains a commitment to nonpartisan analysis, striving to present evidence-based perspectives that transcend ideological boundaries. The institution engages with government officials, corporate executives, nonprofit leaders, and the broader public through publications, conferences, and direct consultation.
Company Leadership JS
AM
SS
SC
The Agency for Science, Technology and Research, also known as A*STAR, is a research organization that advances national priorities in health, economy, sustainability, and future technologies. The agency conducts scientific research and innovation across diverse fields, including electronics, cancer research, chemistry, water treatment, materials science, infectious diseases, genetics, and energy. Its work focuses on developing impactful science, such as energy-efficient AI systems, sustainable molecular catalysts, and novel RNA-based molecular tools, to drive research, innovation, and enterprise in the physical sciences and engineering.
Company Leadership FH
VH
SH
KA
Lummus Technology is a global energy technology and engineering solutions company that develops and licenses process technologies for the refining, petrochemical, and energy industries. The company provides proprietary technologies, catalysts, equipment, and lifecycle services that enable customers to convert raw materials such as crude oil, natural gas, and other feedstocks into fuels, chemicals, and sustainable products
Company Leadership Ld
LB
AP
Inotiv provides deep expertise and scientific capabilities across the discovery and continuum. We support our clients from the beginning of discovery, through investigational new drug (IND) and beyond, all with the aim of delivering a superlative experience. Combined with our long history and deep experience with supply of critical research models, including rodents, rabbits, and nonhuman primates, Inotiv is the right-sized CRO for your next project. With our dedication to attentive, decisive service, you can trust that every program is a priority. Benefit from our long and impeccable regulatory history, world-class team of scientists, and on-time quality data delivery.
Company Leadership RL
JK
Frequently Asked Questions Regarding Worldwide Clinical Trials Top Executives and Leadership Team
